fda approved glp-1 drugs List of and pending medications Compound versions of GLP-1 drugs
Description
Most state Medicaid programs dont cover weight loss drugs for obesity, but that could soon change.
Some sub-analyses of large clinical trials suggest that GLP-1RA and sodium-glucose cotransporter 2 inhibitor combination therapy may provide more significant reductions in heart failure hospitalization and renal composite events than each alone
Little is known about the association of discontinuation of sodium-glucose cotransporter-2 (SGLT2) inhibitors and glucagon-like peptide-1 receptor agonists (GLP-1 RA) with outcomes in patients with CKD
In a trial, people lost 75% fat and 25% muscle.
